Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-27T02:10:57.528Z Has data issue: false hasContentIssue false
  • English
  • Français

The Contribution of Clinical Trials in Psychiatry: A Basic Science of Clinical Care

Published online by Cambridge University Press:  07 November 2014

Andrew A. Nierenberg
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
CNS Spectrums , Volume 14 , Issue 10 , October 2009 , pp. 528 - 529
Copyright
Copyright © Cambridge University Press 2009

References

REFERENCES

1.Avorn, J.Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. New York, NY: Vintage; 2005.Google Scholar
2.Angell, M.The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York, NY: Random House; 2005.Google Scholar
3.Kassirer, J.On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health. New York, NY: Oxford University Press; 2005.Google Scholar
4.Isaacs, D, Fitzgerald, D. Seven alternatives to evidence based medicine. BMJ. 1999;319:1618.Google Scholar
5.Devereaux, PJ, Yusuf, S. The evolution of the randomized controlled trial and its role in evidence-based decision making. J Intern Med. 2003;254:105–113.CrossRefGoogle ScholarPubMed
6.Golder, EM, Bilsker, D. Evidence-based psychiatry. Can J Psychiatry. 1995;40:97–101.Google Scholar
7.Sackett, DL. Evidence-based medicine. Semin Perinatol. 1997;21:305.CrossRefGoogle ScholarPubMed
8.Sackett, DL, Rosenberg, WM. On the need for evidence-based medicine. J Public Health Med. 1995;17:330–334.Google Scholar
9.Horwitz, RI, Singer, BH, Makuch, RW, Viscoli, CM. Can treatment that is helpful on average be harmful to some patients? J Clin Epidemiol. 1996;49:395–400.Google Scholar
10.Carroll, KM, Nich, C, McLellan, AT, McKay, JR, Rounsaville, BJ. ‘Research’ versus ‘real-world’ patients: representativeness of participants in clinical trials of treatments for cocaine dependence. Drug Alcohol Depend. 1999;54:171–177.Google Scholar
11.Rapaport, MH, Frevert, T, Babior, S, Zisook, S, Judd, LL. A comparison of demographic variables, symptom profiles, and measurements of functioning in symptomatic volunteers and an outpatient clinical population. Psychopharmacol Bull. 1995;31:111–114.Google Scholar
12.Stirman, SW, DeRubeis, RJ, Crits-Christoph, P, Brody, PE. Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. J Consult Clin Psychol. 2003;71:963–972.Google Scholar
13.Braslow, JT, Duan, N, Starks, SL, Polo, A, Bromley, E, Wells, KB. Generalizability of studies on mental health treatment and outcomes, 1981 to 1996. Psychiatr Serv. 2005;56:1261–1268.CrossRefGoogle ScholarPubMed
14.Schelling, FA. Clinical trials: deliberations on their essence and value. J Eval Clin Pract. 2004;10:291–296.Google Scholar
15.Fava, GA. The intellectual crisis of psychiatric research. Psychother Psychosom. 2006;75:202–208.CrossRefGoogle ScholarPubMed
16.Wise, TN. Curiosity and crisis. Psychother Psychosom. 2006;75:199–201.Google Scholar